OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating inflammatory markers impact cognitive functions in bipolar depression
Sara Poletti, Mario Gennaio Mazza, F. Calesella, et al.
Journal of Psychiatric Research (2021) Vol. 140, pp. 110-116
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
Mario Gennaro Mazza, Mariagrazia Palladini, Sara Poletti, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 681-702
Open Access | Times Cited: 162

Antidepressant psychopharmacology: is inflammation a future target?
Francesco Benedetti, Raffaella Zanardi, Mario Gennaro Mazza
International Clinical Psychopharmacology (2022) Vol. 37, Iss. 3, pp. 79-81
Closed Access | Times Cited: 39

The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
Adriano José Maia Chaves Filho, Capri Eyres, Leonie Blöbaum, et al.
Journal of Neurochemistry (2024)
Open Access | Times Cited: 6

Inflammatory Biomarkers, Cognitive Functioning, and Brain Imaging Abnormalities in Bipolar Disorder: A Systematic Review.
A Mario, Leccisotti Ivana, Mollica Anita, et al.
PubMed (2024) Vol. 21, Iss. 1, pp. 32-62
Closed Access | Times Cited: 6

Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Developing Post-Acute Depression and Anxiety
Rebecca De Lorenzo, Mario Gennaro Mazza, Clara Sciorati, et al.
CNS Drugs (2024) Vol. 38, Iss. 6, pp. 459-472
Closed Access | Times Cited: 4

Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
Yafen Wang, Weicheng Meng, Zhixin Liu, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 19

Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder?
Xiuhua Wu, Zhongcheng Chen, Yingtao Liao, et al.
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 11

Utilizing systematic Mendelian randomization to identify potential therapeutic targets for mania
Fang-Biao Xu, Sen Hu, Jingjing Wang, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3

The interactions between vitamin D and neurofilament light chain levels on cognitive domains in bipolar disorder
Wen‐Yin Chen, Ming‐Chyi Huang, Chih Chiang Chiu, et al.
BJPsych Open (2022) Vol. 8, Iss. 6
Open Access | Times Cited: 11

The relationship between cognitive clusters and telomere length in bipolar-schizophrenia spectrum disorders
Caroline Gurvich, Natalie Thomas, Abdul‐Rahman Hudaib, et al.
Psychological Medicine (2022) Vol. 53, Iss. 11, pp. 5119-5126
Closed Access | Times Cited: 9

Effective Antidepressant Chronotherapeutics (Sleep Deprivation and Light Therapy) Normalize the IL-1β:IL-1ra Ratio in Bipolar Depression
Francesco Benedetti, Sara Dallaspezia, Elisa Melloni, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 11

Identification of Plasma Inflammatory Markers of Adolescent Depression Using the Olink Proteomics Platform
Ling Yang, Maolin Cao, Jing Tian, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 4489-4501
Open Access | Times Cited: 4

Higher Seasonal Variation of Systemic Inflammation in Bipolar Disorder
Sara Dallaspezia, Vincenzo Cardaci, Mario Gennaro Mazza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4310-4310
Open Access | Times Cited: 1

Effects of low-dose aspirin in bipolar disorder: study protocol for a randomised controlled trial (the A-Bipolar RCT)
Caroline Fussing Bruun, Jeff Zarp, Julie Lyng Forman, et al.
BMJ Open (2024) Vol. 14, Iss. 11, pp. e084105-e084105
Open Access | Times Cited: 1

Inflammatory pathology in depression and suicide: a mechanistic distillation of clinical correlates
Alessandra Costanza, Andrea Amerio, Andrea Aguglia, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Shared postulations between bipolar disorder and polycystic ovary syndrome pathologies
Wenyu Dai, Jieyu Liu, Yan Qiu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 115, pp. 110498-110498
Closed Access | Times Cited: 6

Clinical characteristics of bipolar 1 disorder in relation to interleukin-6: a cross-sectional study among Egyptian patients
May Hassan, Rasha Elzehery, Youssef M. Mosaad, et al.
Middle East Current Psychiatry (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 2

Association between serum omega-3 PUFAs levels and cognitive impairment in never medically treated first-episode patients with geriatric depression: A cross-sectional study
Jing Gao, Huiyu Fan, Xiaohong Wang, et al.
Journal of Affective Disorders (2023) Vol. 346, pp. 1-6
Closed Access | Times Cited: 2

Viral mimicry and memory deficits upon microglial deletion of ATRX
Sarfraz Shafiq, Arsham Ghahramani, K. Mansour, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Involvement of CXCL10 rs4256246, CXCR4 rs2228014, CCR2 rs1799864 and CXCL16 rs2277680 in the Predisposition to Schizophrenia
Hana Saoud, Hajer Foddha, Youssef Aflouk, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 3
Closed Access

Page 1 - Next Page

Scroll to top